Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats

Journal of the American Society of Nephrology

Volumn 16, Issue 7, 2005, Pages 2073-2080

  Kobori, Hiroyuki ^a   Ozawa, Yuri ^a   Suzaki, Yuki ^a   Nishiyama, Akira ^a,b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSINOGEN; HYDRALAZINE; HYDROCHLOROTHIAZIDE; MESSENGER RNA; OLMESARTAN; PROTEIN; RESERPINE; ANGIOTENSIN RECEPTOR ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; GLOMERULOSCLEROSIS; HYPERTENSION; KIDNEY INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; TISSUE INJURY; URINALYSIS; WESTERN BLOTTING; ANIMAL; KIDNEY DISEASE; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSINOGEN; ANIMALS; HYPERTENSION; KIDNEY DISEASES; MALE; RATS; RATS, INBRED SHR;

EID: 27744529624     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004080676     Document Type: Article

References (31)

1. Okamoto K, Tabei R, Fukushima M, Nosaka S, Yamori Y: Further observations of the development of a strain of spontaneously hypertensive rats. Jpn Circ J 30: 703-716, 1966
2. Vincent M, Dupont J, Sassard J: Plasma renin activity as a function of age in two new strains of spontaneously hypertensive and normotensive rats. Clin Sci Mol Med 50: 103-107, 1976
3. Kuriyama S, Kawashima K, Sokabe H: Plasma renin activity determined by two different methods in spontaneously hypertensive rats. Jpn Heart J 23: 587-592, 1982
4. Nakamura Y, Ono H, Zhou X, Frohlich ED: Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats. Hypertension 37: 1262-1267, 2001
5. Teng J, Fukuda N, Suzuki R, Takagi H, Ikeda Y, Tahira Y, Kanmatsuse K: Inhibitory effect of a novel angiotensin II type 1 receptor antagonist RNH-6270 on growth of vascular smooth muscle cells from spontaneously hypertensive rats: Different anti-proliferative effect to angiotensin-converting enzyme inhibitor. J Cardiovasc Pharmacol 39: 161-171, 2002
6. Pu Q, Larouche I, Schiffrin EL: Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats. Am J Hypertens 16: 931-937, 2003
7. Kobori H, Nishiyama A, Abe Y, Navar LG: Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 41: 592-597, 2003
8. Kobori H, Nishiyama A: Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats. Biochem Biophys Res Commun 315: 746-750, 2004
9. Kobori H, Prieto-Carrasquero MC, Ozawa Y, Navar LG: AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 43: 1126-1132, 2004
10. Fabris B, Candido R, Armini L, Fischetti F, Calci M, Bardelli M, Fazio M, Campanacci L, Carretta R: Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats. J Hypertens 17: 1925-1931, 1999
11. Kobori H, Harrison-Bernard LM, Navar LG: Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 12: 431-439, 2001
12. Kobori H, Harrison-Bernard LM, Navar LG: Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension 37: 1329-1335, 2001
13. Kobori H, Harrison-Bernard LM, Navar LG: Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int 61: 579-585, 2002
14. Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG: Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension 41: 42-49, 2003
15. Prieto-Carrasquero MC, Harrison-Bernard LM, Kobori H, Ozawa Y, Hering-Smith KS, Hamm LL, Navar LG: Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension 44: 223-229, 2004
16. Kanda T, Wakino S, Hayashi K, Homma K, Ozawa Y, Saruta T: Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats. Kidney Int 64: 2009-2019, 2003
17. Graciano ML, Cavaglieri RDC, Delle H, Dominguez WV, Casarini DE, Malheiros DMAC, Noronha IL: Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 15: 1805-1815, 2004
18. Carey AV, Carey RM, Gomez RA: Expression of alpha-smooth muscle actin in the developing kidney vasculature. Hypertension 19: II168-II175, 1992
19. Meng QC, Durand J, Chen YF, Oparil S: Effects of dietary salt on angiotensin peptides in kidney. J Am Soc Nephrol 6: 1209-1215, 1995
20. Gould AB, Green D: Kinetics of the human renin and human substrate reaction. Cardiovasc Res 5: 86-89, 1971
21. Brasier AR, Li J: Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 27: 465-475, 1996
22. Nishiyama A, Seth DM, Navar LG: Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 39: 129-134, 2002
23. Nishiyama A, Seth DM, Navar LG: Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition. J Am Soc Nephrol 13: 2207-2212, 2002
24. Siragy HM, Howell NL, Ragsdale NV, Carey RM: Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension 25: 1021-1024, 1995
25. Siragy HM, Carey RM: Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension 33: 1237-1242, 1999
26. Schunkert H, Ingelfinger JR, Jacob H, Jackson B, Bouyounes B, Dzau VJ: Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol 263: E863-E869, 1992
27. Klett C, Nobiling R, Gierschik P, Hackenthal E: Angiotensin II stimulates the synthesis of angiotensinogen in hepatocytes by inhibiting adenylylcyclase activity and stabilizing angiotensinogen mRNA. J Biol Chem 268: 25095-25107, 1993
28. Li J, Brasier AR: Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: One mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol 10: 252-264, 1996
29. Tamura K, Umemura S, Nyui N, Hibi K, Ishigami T, Kihara M, Toya Y, Ishii M: Activation of angiotensinogen gene in cardiac myocytes by angiotensin II and mechanical stretch. Am J Physiol 275: R1-R9, 1998
30. Mascareno E, Dhar M, Siddiqui MA: Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: A cellular signal for hypertrophy in cardiac muscle. Proc Natl Acad Sci U S A 95: 5590-5594, 1998
31. Ingelfinger JR, Jung F, Diamant D, Haveran L, Lee E, Brem A, Tang SS: Rat proximal tubule cell line transformed with origin-defective SV40 DNA: Autocrine ANG II feedback. Am J Physiol 276: F218-F227, 1999